These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14614561)

  • 1. IA-2 is not required for the development of diabetes in NOD mice.
    Kubosaki A; Miura J; Notkins AL
    Diabetologia; 2004 Jan; 47(1):149-50. PubMed ID: 14614561
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoantibodies to IA-2 not detected in NOD mice or BB rats.
    DeSilva MG; Jun HS; Yoon JW; Notkins AL; Lan MS
    Diabetologia; 1996 Oct; 39(10):1237-8. PubMed ID: 8897014
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
    Leslie RD; Atkinson MA; Notkins AL
    Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of proteolytic cleavages of diabetes-associated protein IA-2 beta in the pancreas and the brain using novel anti-IA-2 beta monoclonal antibodies.
    Kawakami T; Saeki K; Takeyama N; Wu G; Sakudo A; Matsumoto Y; Hayashi T; Onodera T
    Int J Mol Med; 2007 Aug; 20(2):177-85. PubMed ID: 17611635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies directed against the ectodomain of ICA512: is there any evidence in patients with diabetes mellitus?
    Schiel R
    Diabetologia; 1998 Dec; 41(12):64-5. PubMed ID: 9867225
    [No Abstract]   [Full Text] [Related]  

  • 6. Dense core vesicle proteins IA-2 and IA-2beta: metabolic alterations in double knockout mice.
    Kubosaki A; Nakamura S; Notkins AL
    Diabetes; 2005 Dec; 54 Suppl 2():S46-51. PubMed ID: 16306340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to ICA512/IA-2 in rodent models of IDDM.
    Myers MA; Laks MR; Feeney SJ; Mandel TE; Koulmanda M; Bone A; Barley J; Rowley MJ; Mackay IR
    J Autoimmun; 1998 Jun; 11(3):265-72. PubMed ID: 9693975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does GAD have a unique role in triggering IDDM?
    Baekkeskov S; Kanaani J; Jaume JC; Kash S
    J Autoimmun; 2000 Nov; 15(3):279-86. PubMed ID: 11040068
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice.
    Kubosaki A; Gross S; Miura J; Saeki K; Zhu M; Nakamura S; Hendriks W; Notkins AL
    Diabetes; 2004 Jul; 53(7):1684-91. PubMed ID: 15220191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and autoantibodies to IA-2 in children with type 1 diabetes.
    Cianfarani S; Bonfanti R; Manca Bitti ML; Chiumello G; Boscherini B
    Lancet; 2000 Oct; 356(9240):1521. PubMed ID: 11081554
    [No Abstract]   [Full Text] [Related]  

  • 11. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
    J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DQ8 transgenic and NOD mice recognize different epitopes within the cytoplasmic region of the tyrosine phosphatase-like molecule, IA-2.
    Kudva YC; Deng YJ; Govindarajan R; Abraham RS; Marietta EV; Notkins AL; David CS
    Hum Immunol; 2001 Oct; 62(10):1099-105. PubMed ID: 11600216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-dependent diabetes mellitus and its animal models.
    Wong FS; Janeway CA
    Curr Opin Immunol; 1999 Dec; 11(6):643-7. PubMed ID: 10631549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering and expression of the intracellular domain of insulinoma-associated tyrosine phosphatase (IA-2ic), a type 1 diabetes autoantigen, in plants.
    Mett V; Shamloul AM; Hirai H; Zhou Z; Notkins A; Yusibov V
    Transgenic Res; 2007 Feb; 16(1):77-84. PubMed ID: 17103024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization therapies in the prevention of diabetes.
    Ramiya VK; Lan MS; Wasserfall CH; Notkins AL; Maclaren NK
    J Autoimmun; 1997 Jun; 10(3):287-92. PubMed ID: 9218756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
    Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
    J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping to chromosomes 1 and 12 of mouse homologs of human protein tyrosine phosphatase, receptor-type, related genes encoding pancreatic beta cell autoantigens.
    Leiter EH; Tsumura H; Serreze DV; Chapman HD; Rabin DU; Lan MS; Notkins AL
    Mamm Genome; 1997 Dec; 8(12):949-50. PubMed ID: 9383296
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of IA-2 with IA-2beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera.
    Notkins AL; Zhang B; Matsumoto Y; Lan MS
    J Autoimmun; 1997 Jun; 10(3):245-50. PubMed ID: 9218750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
    Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
    J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.